Amgen

The Amgen Foundation is committing $13.4 million to the Amgen Biotech Experience (ABE) through the 2027–28 school year, helping bring hands-on biotechnology education to students around the world.   This latest commitment brings the Foundation’s total support for ABE to more than $75 million. Each year, the program reaches 100,000 students and provides participating schools with biotechnology curriculum, professional development, equipment and lab supplies at no cost. ABE helps: 🔹 Students explore biotechnology through hands-on learning 🔹 Teachers build their skills with specialized training and resources 🔹 Communities expand access to high-quality science education   Because the future of biotech starts in the classroom.   Learn more: https://amgen.ly/4i0Xlob

For too long, advances for people with extensive-stage small cell lung cancer were limited. Now, continued scientific innovation is opening the door to new possibilities.     We're grateful to the advocacy leaders who shared their perspectives on the progress they are seeing across the SCLC landscape and the hope it brings to patients, care partners and the broader community.     As oncology experts from around the world prepare to gather at the ESMO - European Society for Medical Oncology Congress, we’re reminded of who sits at the heart of progress: the people at the center of cancer research.

At the joint Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) and ECTRIMS meeting, Amgen is presenting real-world data that contribute to a broader understanding of neuromyelitis optica spectrum disorder (NMOSD).    Real-world evidence can provide important insights into how rare diseases are managed in clinical practice.    #MSToronto2026

📢 Amgen announced positive full Phase 3 results in eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus that can make swallowing and eating challenging. 🔗 Learn more: https://amgen.ly/4dPZxfL $AMGN

For Dona, an unexpected fracture at a yoga retreat led to a postmenopausal osteoporosis diagnosis she never saw coming. But with support from her doctor and a clear path forward, she began to strengthen her bones. At Amgen, we’re working to change the story of postmenopausal osteoporosis care so a fracture becomes a wake-up call, not a missed opportunity.  This #WorldOsteoporosisDay, watch Dona’s story and hear what she wants more women to know. Learn more: https://amgen.ly/4dNLAPi

At Amgen’s third annual Obesity Symposium, we brought together leaders across healthcare, advocacy and business to explore the rapidly evolving expectations for care.   Progress is only possible when we listen, learn and work across the obesity ecosystem.   Here are five takeaways from the event. ⬇️

Big careers can start with a single opportunity. At Amgen’s Puerto Rico site, our Undergraduate Co-op Program gives students the opportunity to apply what they're learning in the classroom, gain hands-on experience, and work alongside teams helping advance our mission to serve patients. Hear directly from our participants as they share how their co-op experience helped them grow, explore their passions, and make meaningful contributions from day one. Ready to start your own journey? Explore our latest Co-Op opportunities and apply now: https://lnkd.in/g6zh4JFe #AmgenCareers #EarlyCareers

Innovation has been at the heart of Amgen since our founding more than 45 years ago—and it continues to shape how we serve patients today. Amgen has been ranked #4 on Forbes’ inaugural list of America’s Most Innovative Large Companies, recognizing the company among the nation’s leaders in innovation. The ranking evaluated companies across the S&P 500 using measures including R&D, intellectual property activity, investor confidence, and perceptions of innovation. We’re continuing to harness the best of biology and technology to help fight the world’s toughest diseases, and deliver innovative medicines for patients around the world.

Amgen Mission Week 2026 is a wrap! Here’s a look at how our global community came together during the week to hear directly from patients and the people who support them. Their experiences remind us why our mission to serve patients matters in the work we do every day.  #AmgenMissionWeek2026

At #ASBMR2026, we’re on the ground discussing what it takes to move postmenopausal osteoporosis care forward.  From improved education and screening to stronger post-fracture care pathways, Amgen leaders are weighing in on how we can close gaps and help ensure more patients get the care they need.  Swipe to see what they’re saying.